Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers

Clinical trial NCT03785210 · TERMINATED

Trial details

NCT number: NCT03785210
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Hepatocellular Cancer Metastatic Pancreatic Cancer Metastatic Colorectal Cancer Liver Metastasis

Start date: 2019-06-05
Primary completion: 2022-10-31
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.